KLK3 and neoplasm: Oral administration of carnosol (30 mg/kg/day) 5 days per week for 4 weeks to athymic nude mice implanted with AR and ER-α positive 22Rv1 cells reduced tumour growth by 36% and reduced serum prostate specific antigen levels by 26% [44].